Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma

Clinical Science

Volumn 99, Issue 3, 2000, Pages 207-214

  Okubo, M ^a   Shiota, G ^a   Kawasaki, H ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis; Hepatocellular carcinoma; Hypersplenism; Thrombocytopenia; Thrombopoietin

Indexed keywords

INDOCYANINE GREEN; MESSENGER RNA; SERUM ALBUMIN; THROMBOPOIETIN;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HYPERSPLENISM; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; VIRUS HEPATITIS;

EID: 0033811597     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0990207     Document Type: Article

References (33)

1. Pooling of platelets in the spleen: Role in the pathogenesis of 'hypersplenic' thrombocytopenia
2. Thrombokinetics in man
3. Platelet dynamics in chronic liver diseases with special reference to the role of the spleen
4. Correction of hypersplenism following distal splenorenal shunt
5. Partial portal pressure decompression alleviates thrombocytopenia of portal hypertension
6. The hematologic consequences of transjugular intrahepatic portosystemic shunts
7. Improvement of thrombocytopenia due to hypertension after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients
8. The choice of shunt procedure for cirrhotic patients with variceal bleeding, ascites and hypersplenism
9. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
10. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
11. Identification and cloning of a megakaryocyte growth factor and development factor that is a ligand for the cytokine receptor Mpl
12. Molecular cloning and chromosomal location of the human thrombopoietin gene
13. Thrombopoietin: The primary regulator of platelet production
14. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: Serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders
15. The purification of megaropoietin: A physiological regulator of megakaryocyte growth and platelet production
16. Murine thrombopoietin mRNA levels are modulated by platelet count
17. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets
18. Production of thrombopoietln (TPO) by rat hepatocytes and hepatoma cell lines
19. Constitutive expression of the thrombopoietin gene in a human hepatoma cell line
20. Is inadequate thrombopoietin a major cause of thrombocytopenia in cirrhosis of the liver?
21. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation
22. Direct evidence for an increase in thrombopoiesis after liver transplantation
23. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotropic liver transplantation
24. Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis
25. Sonographic assessment and grading of spleen size
26. Histological diagnosis of hepatocellular carcinoma by a new technique of ultrasound-guided fine needle biopsy
27. Circulating thrombopoietin concentrations in thrombocytopenic patients including cancer patients following chemotherapy with or without peripheral blood progenitor cell transplantation
28. Interferon increases serum thrombopoietin in patients with chronic hepatitis C
29. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: A multicenter study
30. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction
31. Expression of thrombopoietin mRNA in the liver of patients with chronic liver disease
32. Deficiencies in early and late stages megakaryocytopoiesis in TPO-KO mice